Marketing authorization holders who want to temporarily supply a medicine in a different packaging in the event of a medicine shortage will need permission from the MEB from 1 January 2023. The MEB will take over this task from the Healthcare and Youth Inspectorate (IGJ).
In case of medicine shortages, (temporarily) supplying medicines from another country can offer solutions to patients. This concerns a specific situation with serious problems regarding the availability of the medicine. Marketing authorization holders can continue to submit a request for temporarily deviating packaging (TAV) via the reporting form of the Medicines Shortages and Defects Reporting Point.